4//SEC Filing
Tari Leslie 4
Accession 0001610618-25-000023
CIK 0001610618other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 6:33 PM ET
Size
6.5 KB
Accession
0001610618-25-000023
Insider Transaction Report
Form 4
Tari Leslie
CHIEF SCIENTIFIC OFFICER
Transactions
- Sale
Common Stock
2025-03-11$21.96/sh−1,773$38,940→ 16,215 total
Holdings
- 73(indirect: By Spouse)
Common Stock
Footnotes (3)
- [F1]The sale represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.96 to $22.26, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F3]Includes 200 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on November 20, 2024.
Documents
Issuer
Cidara Therapeutics, Inc.
CIK 0001610618
Entity typeother
Related Parties
1- filerCIK 0001870270
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 6:33 PM ET
- Size
- 6.5 KB